Trial intelligence / Profile preview

Methadone and Ketamine for Neuropathic Pain

NCT02233452Phase 4Completed

Sponsor
Universidade Federal de Santa Maria
Start
Jan 2012
Primary completion
Aug 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in neuropathic pain comparing Methadone, Ketamine and Methadone + Ketamine (3 arms). Primary endpoint: Pain intensity assessed by Visual Analogical Scale at 90 days. Started Jan 2012; status: completed.

02

Drugs

methadoneketamine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02233452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02233452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call